Cargando…

A Nomogram for Identifying Subclinical Atherosclerosis in Chronic Kidney Disease

PURPOSE: Atherosclerosis contributes substantially to cardiovascular mortality in patients with chronic kidney disease (CKD). But precise risk model for subclinical atherosclerosis in the CKD population is still lacking. The study aimed to develop and validate a nomogram for screening subclinical at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Jiachuan, Yu, Zhikai, Zhang, Daohai, Huang, Yinghui, Yang, Ke, Zhao, Jinghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275156/ https://www.ncbi.nlm.nih.gov/pubmed/34267510 http://dx.doi.org/10.2147/CIA.S312129

Ejemplares similares

T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease
por: Xiong, Jiachuan, et al.
Publicado: (2021)

Antiplatelet therapy for the prevention of atherosclerosis in chronic kidney disease (ALTAS-CKD) patients: study protocol for a randomized clinical trial
por: Xiong, Jiachuan, et al.
Publicado: (2021)

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
por: Huang, Yinghui, et al.
Publicado: (2022)

Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease
por: Li, Haiyang, et al.
Publicado: (2022)

Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications
por: Gong, Shuiqin, et al.
Publicado: (2022)

Arteriolar hyalinosis and renal outcomes in patients with immunoglobulin A nephropathy
por: Shen, Yunzhu, et al.
Publicado: (2022)

Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
por: Guan, Xu, et al.
Publicado: (2022)

The effectiveness of multidisciplinary care models for patients with chronic kidney disease: a systematic review and meta-analysis
por: Shi, Yu, et al.
Publicado: (2017)

Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review
por: Kousios, Andreas, et al.
Publicado: (2016)

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
por: Palanca, Ana, et al.
Publicado: (2019)

Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease
por: Donate-Correa, Javier, et al.
Publicado: (2021)

Controlling nutritional status score is associated with renal progression, cardiovascular events, and all-cause mortality in biopsy-proved diabetic kidney disease
por: Huo, Qingyu, et al.
Publicado: (2023)

Synthesis and Characterization of Fucoidan-Chitosan Nanoparticles Targeting P-Selectin for Effective Atherosclerosis Therapy
por: Liu, Mingying, et al.
Publicado: (2022)

Mitochondrial Damage‐Induced Innate Immune Activation in Vascular Smooth Muscle Cells Promotes Chronic Kidney Disease‐Associated Plaque Vulnerability
por: Bi, Xianjin, et al.
Publicado: (2021)

Undercarboxylated osteocalcin as a biomarker of subclinical atherosclerosis in non-dialysis patients with chronic kidney disease
por: Zhang, Minfang, et al.
Publicado: (2015)

Serum Endocan Levels and Subclinical Atherosclerosis in Patients with Chronic Kidney and End-Stage Renal Diseases
por: El-Senosy, Fatma M., et al.
Publicado: (2022)

Targeting Myocardial Mitochondria-STING-Polyamine Axis Prevents Cardiac Hypertrophy in Chronic Kidney Disease
por: Han, Wenhao, et al.
Publicado: (2022)

Subclinical Atherosclerosis in Patients with Chronic Non-Dialytic Renal Disease
por: Borges, Wagner Ramos, et al.
Publicado: (2015)

Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study
por: Sánchez, Enric, et al.
Publicado: (2017)

Kidney Function and Subclinical Arrhythmias: The Multi-Ethnic Study of Atherosclerosis
por: Wiggins, Kerri L., et al.
Publicado: (2021)

DUSP2-mediated inhibition of tubular epithelial cell pyroptosis confers nephroprotection in acute kidney injury
por: Xiong, Jiachuan, et al.
Publicado: (2022)

Associations of kidney injury markers with subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis
por: Park, Meyeon, et al.
Publicado: (2015)

Clinical significance of subclinical carotid atherosclerosis and its relationship with echocardiographic parameters in non-diabetic chronic kidney disease patients
por: Kim, Jwa-Kyung, et al.
Publicado: (2013)

Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy
por: Bolignano, Davide, et al.
Publicado: (2022)

Effect of Levothyroxine on Kidney Function in Chronic Kidney Disease with Subclinical Hypothyroidism in US Veterans: A Retrospective Observational Cohort Study
por: Hennessey, James V., et al.
Publicado: (2020)

The RIFLE versus AKIN classification for incidence and mortality of acute kidney injury in critical ill patients: A meta-analysis
por: Xiong, Jiachuan, et al.
Publicado: (2015)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Predictors of subclinical atherosclerosis in HIV
por: Fernández Soto, Julia, et al.
Publicado: (2023)

IRF1-mediated downregulation of PGC1α contributes to cardiorenal syndrome type 4
por: Huang, Yinghui, et al.
Publicado: (2020)

Frequency of Subclinical Hypothyroidism in Patients With Chronic Kidney Disease
por: Anum, FNU, et al.
Publicado: (2022)

Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly
por: Kuller, Lewis H., et al.
Publicado: (2017)

Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study
por: Jia, Yu, et al.
Publicado: (2022)

Subclinical atherosclerosis in northern and southern China: the Chinese paradox
por: Huang, Jie, et al.
Publicado: (2011)

REST contributes to AKI-to-CKD transition through inducing ferroptosis in renal tubular epithelial cells
por: Gong, Shuiqin, et al.
Publicado: (2023)

Noninvasive indicators of atherosclerosis in subclinical hypothyroidism
por: Kilic, Ismail Dogu, et al.
Publicado: (2013)

Association of Fat Density With Subclinical Atherosclerosis
por: Alvey, Nicholas J., et al.
Publicado: (2014)

Subclinical atherosclerosis: how and when to treat it?
por: Gatto, Laura, et al.
Publicado: (2020)

Biomarkers of subclinical atherosclerosis in patients with psoriasis
por: Kaiser, Hannah, et al.
Publicado: (2021)

Subclinical cardiopulmonary dysfunction in stage 3 chronic kidney disease
por: Nelson, Alexander, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_59a2kbbaut02uk3celq59qglg2